Copyright Reports & Markets. All rights reserved.

Global Biomarker (Medicine) Market Insights, Forecast to 2025

Buy now

Table of Contents

    Global Biomarker (Medicine) Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Biomarker (Medicine) Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Biomarker (Medicine) Market Size Growth Rate by Type
        • 1.4.2 Safety Biomarker
        • 1.4.3 Validation Biomarker
        • 1.4.4 Efficacy Biomarker
      • 1.5 Market by Application
        • 1.5.1 Global Biomarker (Medicine) Market Size Growth Rate by Application
        • 1.5.2 Oncology
        • 1.5.3 Cardiology
        • 1.5.4 Neurology
        • 1.5.5 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Biomarker (Medicine) Production
        • 2.1.1 Global Biomarker (Medicine) Revenue 2014-2025
        • 2.1.2 Global Biomarker (Medicine) Production 2014-2025
        • 2.1.3 Global Biomarker (Medicine) Capacity 2014-2025
        • 2.1.4 Global Biomarker (Medicine) Marketing Pricing and Trends
      • 2.2 Biomarker (Medicine) Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Biomarker (Medicine) Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Biomarker (Medicine) Production by Manufacturers
        • 3.1.1 Biomarker (Medicine) Production by Manufacturers
        • 3.1.2 Biomarker (Medicine) Production Market Share by Manufacturers
      • 3.2 Biomarker (Medicine) Revenue by Manufacturers
        • 3.2.1 Biomarker (Medicine) Revenue by Manufacturers (2014-2019)
        • 3.2.2 Biomarker (Medicine) Revenue Share by Manufacturers (2014-2019)
      • 3.3 Biomarker (Medicine) Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Biomarker (Medicine) Production by Regions

      • 4.1 Global Biomarker (Medicine) Production by Regions
        • 4.1.1 Global Biomarker (Medicine) Production Market Share by Regions
        • 4.1.2 Global Biomarker (Medicine) Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Biomarker (Medicine) Production
        • 4.2.2 United States Biomarker (Medicine) Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Biomarker (Medicine) Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Biomarker (Medicine) Production
        • 4.3.2 Europe Biomarker (Medicine) Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Biomarker (Medicine) Import & Export
      • 4.4 China
        • 4.4.1 China Biomarker (Medicine) Production
        • 4.4.2 China Biomarker (Medicine) Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Biomarker (Medicine) Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Biomarker (Medicine) Production
        • 4.5.2 Japan Biomarker (Medicine) Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Biomarker (Medicine) Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Biomarker (Medicine) Consumption by Regions

      • 5.1 Global Biomarker (Medicine) Consumption by Regions
        • 5.1.1 Global Biomarker (Medicine) Consumption by Regions
        • 5.1.2 Global Biomarker (Medicine) Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Biomarker (Medicine) Consumption by Application
        • 5.2.2 North America Biomarker (Medicine) Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Biomarker (Medicine) Consumption by Application
        • 5.3.2 Europe Biomarker (Medicine) Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Biomarker (Medicine) Consumption by Application
        • 5.4.2 Asia Pacific Biomarker (Medicine) Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Biomarker (Medicine) Consumption by Application
        • 5.5.2 Central & South America Biomarker (Medicine) Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Biomarker (Medicine) Consumption by Application
        • 5.6.2 Middle East and Africa Biomarker (Medicine) Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Biomarker (Medicine) Breakdown Dada by Type
      • 6.2 Global Biomarker (Medicine) Revenue by Type
      • 6.3 Biomarker (Medicine) Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Biomarker (Medicine) Breakdown Dada by Application
        • 7.2.1 Global Biomarker (Medicine) Consumption by Application
        • 7.2.2 Global Biomarker (Medicine) Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Roche
        • 8.1.1 Roche Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Biomarker (Medicine)
        • 8.1.4 Biomarker (Medicine) Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Dako (Agilent Technologies)
        • 8.2.1 Dako (Agilent Technologies) Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Biomarker (Medicine)
        • 8.2.4 Biomarker (Medicine) Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Merck
        • 8.3.1 Merck Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Biomarker (Medicine)
        • 8.3.4 Biomarker (Medicine) Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 BD
        • 8.4.1 BD Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Biomarker (Medicine)
        • 8.4.4 Biomarker (Medicine) Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 Abbott
        • 8.5.1 Abbott Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Biomarker (Medicine)
        • 8.5.4 Biomarker (Medicine) Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Genesys Biolabs
        • 8.6.1 Genesys Biolabs Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Biomarker (Medicine)
        • 8.6.4 Biomarker (Medicine) Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 20/20Genesystems
        • 8.7.1 20/20Genesystems Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Biomarker (Medicine)
        • 8.7.4 Biomarker (Medicine) Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 Affymetrix
        • 8.8.1 Affymetrix Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Biomarker (Medicine)
        • 8.8.4 Biomarker (Medicine) Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 Agendia
        • 8.9.1 Agendia Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Biomarker (Medicine)
        • 8.9.4 Biomarker (Medicine) Product Description
        • 8.9.5 SWOT Analysis
      • 8.10 Almac
        • 8.10.1 Almac Company Details
        • 8.10.2 Company Description
        • 8.10.3 Capacity, Production and Value of Biomarker (Medicine)
        • 8.10.4 Biomarker (Medicine) Product Description
        • 8.10.5 SWOT Analysis
      • 8.11 Arrayit
      • 8.12 Biocartic
      • 8.13 Bg Medicine
      • 8.14 Kegg Expression Database
      • 8.15 Thermo Fisher
      • 8.16 BGI

      9 Production Forecasts

      • 9.1 Biomarker (Medicine) Production and Revenue Forecast
        • 9.1.1 Global Biomarker (Medicine) Production Forecast 2019-2025
        • 9.1.2 Global Biomarker (Medicine) Revenue Forecast 2019-2025
      • 9.2 Biomarker (Medicine) Production and Revenue Forecast by Regions
        • 9.2.1 Global Biomarker (Medicine) Revenue Forecast by Regions
        • 9.2.2 Global Biomarker (Medicine) Production Forecast by Regions
      • 9.3 Biomarker (Medicine) Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Biomarker (Medicine) Production Forecast by Type
        • 9.4.2 Global Biomarker (Medicine) Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Biomarker (Medicine) Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Biomarker (Medicine) Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Biomarker (Medicine) Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Biomarker (Medicine) Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Biomarker (Medicine) Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Biomarker (Medicine) Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Biomarker (Medicine) Upstream Market
        • 11.1.1 Biomarker (Medicine) Key Raw Material
        • 11.1.2 Typical Suppliers of Key Biomarker (Medicine) Raw Material
        • 11.1.3 Biomarker (Medicine) Raw Material Market Concentration Rate
      • 11.2 Biomarker (Medicine) Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Biomarker (Medicine) Distributors
      • 11.5 Biomarker (Medicine) Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Global Biomarker (Medicine) market size will increase to Million US$ by 2025, from Million US$ in 2018, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biomarker (Medicine).

        This report researches the worldwide Biomarker (Medicine) market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
        This study categorizes the global Biomarker (Medicine) breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

        The following manufacturers are covered in this report:
        Roche
        Dako (Agilent Technologies)
        Merck
        BD
        Abbott
        Genesys Biolabs
        20/20Genesystems
        Affymetrix
        Agendia
        Almac
        Arrayit
        Biocartic
        Bg Medicine
        Kegg Expression Database
        Thermo Fisher
        BGI

        Biomarker (Medicine) Breakdown Data by Type
        Safety Biomarker
        Validation Biomarker
        Efficacy Biomarker
        Biomarker (Medicine) Breakdown Data by Application
        Oncology
        Cardiology
        Neurology
        Others

        Biomarker (Medicine) Production Breakdown Data by Region
        United States
        Europe
        China
        Japan
        Other Regions

        Biomarker (Medicine) Consumption Breakdown Data by Region
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Malaysia
        Philippines
        Thailand
        Vietnam
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Rest of South America
        Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa
        Rest of Middle East & Africa

        The study objectives are:
        To analyze and research the global Biomarker (Medicine) capacity, production, value, consumption, status and forecast;
        To focus on the key Biomarker (Medicine) manufacturers and study the capacity, production, value, market share and development plans in next few years.
        To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Biomarker (Medicine) :
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025
        For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Buy now